Published in J Pharm Sci on January 01, 1984
Interaction between various polymerized human albumins and hepatitis B surface antigen. J Virol (1985) 0.91
Composition of protein supplements used for human embryo culture. J Assist Reprod Genet (2014) 0.91
Human albumin solution for patients with cirrhosis and acute on chronic liver failure: Beyond simple volume expansion. World J Hepatol (2016) 0.76
The impact of the protein stabilizer octanoic acid on embryonic development and fetal growth in a murine model. J Assist Reprod Genet (2015) 0.75
The epsilon-(gamma-glutamyl)lysine crosslink and the catalytic role of transglutaminases. Adv Protein Chem (1977) 3.37
Epidemiological characteristics and risk factors of hepatocellular carcinoma. J Gastroenterol Hepatol (1997) 2.66
Major urinary protein complex of normal mice: origin. Science (1965) 2.39
[Cross-link in fibrin polymerized by factor 13: epsilon-(gamma-glutamyl)lysine]. Science (1968) 1.96
Hepatitis C transmission associated with intravenous immunoglobulins. Lancet (1995) 1.87
Fibrin sealant: summary of a conference on characteristics and clinical uses. Transfusion (1995) 1.54
Epidemiology of hepatitis B virus infection in the Asia-Pacific region. J Gastroenterol Hepatol (2000) 1.52
Anti-HCV screening and plasma fractionation: the case against. Lancet (1990) 1.48
Reduction of platelet glycoprotein Ib in uraemia. Br J Haematol (1991) 1.40
Considerations of pool size in the manufacture of plasma derivatives. Transfusion (1996) 1.38
Human fibrinogen heterogeneities. I. Structural and related studies of plasma fibrinogens which are high solubility catabolic intermediates. J Biol Chem (1972) 1.37
Establishment of the first World Health Organization International Standard for human parvovirus B19 DNA nucleic acid amplification techniques. Vox Sang (2002) 1.35
Components of the major urinary protein complex in inbred mice: separation and peptide mapping. Biochem Genet (1968) 1.34
Increased phosphorylation of specific nuclear proteins in superior cervical ganglia and PC12 cells in response to nerve growth factor. J Biol Chem (1980) 1.28
Components of the major urinary protein complex of inbred mice: determination of NH2-terminal sequences and comparison with homologous components from wild mice. Biochem Genet (1974) 1.25
Location of the Mup-a locus on mouse linkage group 8. Genet Res (1969) 1.20
Chemical and enzymic detection of protein cross-links. Measurement of epsilon-(gamma-glutamyl)lysine in fibrin polymerized by factor XIII. Biochemistry (1969) 1.18
Chromatographic separation of puberty accelerating pheromone from male mouse urine. Biol Reprod (1976) 1.10
Survival of human coronaviruses 229E and OC43 in suspension and after drying onsurfaces: a possible source ofhospital-acquired infections. J Hosp Infect (2000) 1.09
Partitioning of hepatitis C virus during Cohn-Oncley fractionation of plasma. Transfusion (1993) 1.06
Major urinary protein and immunoglobulin allotypes of recombinant inbred mouse strains. Genet Res (1973) 1.06
Fibrinogen Bethesda: a congenital dysfibrinogenemia with delayed fibrinopeptide release. J Clin Invest (1971) 1.06
Linkage of one component of the major urinary protein complex of mice to the brown coat color locus. Genet Res (1967) 1.06
Hypotension associated with prekallikrein activator (Hageman-factor fragments) in plasma protein fraction. N Engl J Med (1978) 1.05
Human fibrinogen heterogeneities. 3. Identification of chain variants. J Biol Chem (1972) 1.04
Kinetics of activation and autoactivation of human factor XII. Biochemistry (1984) 1.03
Separation of subfractions of human beta-2-glycoprotein I. Biochim Biophys Acta (1967) 1.03
Chronic hepatitis B carriers with null genotypes of glutathione S-transferase M1 and T1 polymorphisms who are exposed to aflatoxin are at increased risk of hepatocellular carcinoma. Am J Hum Genet (1996) 1.02
Comparison of human plasma fibrinogen subfractions and early plasmic fibrinogen derivatives. J Biol Chem (1974) 1.01
Immunoglobulin G dimer: an idiotype-anti-idiotype complex. Mol Immunol (1988) 1.00
The essential covalent structure of human fibrinogen evinced by analysis of derivatives formed during plasmic hydrolysis. J Biol Chem (1973) 0.99
Generation of the combined prothrombin activation peptide (F1-2) during the clotting of blood and plasma. J Clin Invest (1977) 0.99
Epsilon-(gamma glutamyl) lysine in fibrin: lack of crosslink formation in Factor 13 deficiency. Proc Natl Acad Sci U S A (1971) 0.96
Activation of human prothrombin by a procoagulant fraction from the venom of Echis carinatus. Identification of a high molecular weight intermediate with thrombin activity. J Biol Chem (1975) 0.96
Collaborative study to establish a World Health Organization International genotype panel for parvovirus B19 DNA nucleic acid amplification technology (NAT)-based assays. Vox Sang (2011) 0.91
Interaction between various polymerized human albumins and hepatitis B surface antigen. J Virol (1985) 0.91
Human fibrinogen heterogeneities. II. Cross-linking capacity of high solubility catabolic intermediates. J Biol Chem (1972) 0.88
Congenital dysfibrinogenemias. Ann Intern Med (1972) 0.86
Effects of lipid A and liposomes containing lipid A on platelet and fibrinogen production in rabbits. Blood (1980) 0.86
A nested case-control study on association between hepatitis C virus antibodies and primary liver cancer in a cohort of 9,775 men in Taiwan. J Med Virol (1994) 0.85
Gel electrophoresis for assessing fibrin crosslinking: a precaution. Clin Chim Acta (1972) 0.85
Contact-activated factors: contaminants of immunoglobulins preparations with coagulant and vasoactive properties. J Lab Clin Med (1980) 0.85
Nerve growth factor and the activity of tyrosine hydroxylase in organ cultures of rat superior cervical ganglia. J Neurochem (1977) 0.84
Increased phosphorylation of a specific nuclear protein in rat superior cervical ganglia in response to nerve growth factor. Biochem Biophys Res Commun (1978) 0.84
The de novo synthesis of tyrosine hydroxylase in rat superior cervical ganglia in vitro: the effect of nerve growth factor. J Neurochem (1977) 0.84
Frozen platelets and platelet substitutes in transfusion medicine. Transfusion (1997) 0.82
Growth, body composition, and plasma androgen concentration of male broiler chickens subjected to different regimens of photoperiod and light intensity. Poult Sci (1992) 0.81
Assessment of markers of hepatitis C virus infection in a Japanese adult population. J Infect Dis (2001) 0.80
Chronological changes in genetic variance and heritability of anthropometric characteristics among Chinese twin infants. Acta Genet Med Gemellol (Roma) (1990) 0.80
Standardization of the antibody to hepatitis A virus (anti-HAV) content of immunoglobulin. Dev Biol Stand (1983) 0.80
Preparation of beta-XIIa (Hageman factor fragment) from human plasma. Thromb Res (1982) 0.80
Activation of factor XII by dextran sulfate: the basis for an assay of factor XII. Blood (1983) 0.80
The search for the structure of fibrinogen. Prog Hemost Thromb (1976) 0.80
A recombinant single chain antibody neutralizes coronavirus infectivity but only slightly delays lethal infection of mice. Eur J Immunol (1997) 0.80
L-myc, GST M1 genetic polymorphism and hepatocellular carcinoma risk among chronic hepatitis B carriers. Cancer Lett (1996) 0.80
The effect on the safety of intravenous immunoglobulin of testing plasma for antibody to hepatitis C. Transfusion (1994) 0.79
Hemolysis and acute renal failure due to the administration of albumin diluted in sterile water. Transfusion (1999) 0.79
Calibration of the second International Standard for hepatitis B immunoglobulin in an international collaborative study. Vox Sang (2010) 0.79
Letter: The fibrinogenolytic pathway of fibrinogen catabolism: a rebuttal. Thromb Res (1974) 0.79
Stability of immune serum globulin during storage: effects of prior heating. Vox Sang (1969) 0.78
Therapeutic plasma fractions and plasma fractionation (prologue). Semin Thromb Hemost (1979) 0.78
A new congenital abnormality of human fibrinogen. Fibrinogen Bethesda II. Thromb Diath Haemorrh (1973) 0.78
Epsilon-(gamma-glutamyl) lysine cross-links: determination in fibrin from normal and factor XIII-deficient individuals. Ann N Y Acad Sci (1972) 0.78
Rabbit fibrinogen: time course of constituent chain production in vivo. Arch Biochem Biophys (1982) 0.78
Two forms of the human prothrombin converting enzyme (active factor X). Proc Soc Exp Biol Med (1971) 0.78
Housedust mite allergens and IgG. Lancet (1992) 0.77
Amino acid sequence of chicken fibrinopeptide A. Biochim Biophys Acta (1978) 0.77
Immune globulins. Semin Thromb Hemost (1979) 0.77
Levels of anti-A and anti-B in commercial immune globulins. Transfusion (1980) 0.77
Stabilization of human albumin by caprylate and acetyltryptophanate. Vox Sang (1984) 0.77
Secular trend and associated factors of twinning in Taiwan. Acta Genet Med Gemellol (Roma) (1992) 0.77
A global standard for anti-D immunoglobulin: international collaborative study to evaluate a candidate preparation. Vox Sang (2003) 0.77
International collaborative study to evaluate candidate reference reagents to standardize haemagglutination testing for anti-A and anti-B in normal intravenous immunoglobulin products. Vox Sang (2009) 0.76
International collaborative study to establish reference preparations to standardise haemagglutination testing for anti-A and anti-B in normal intravenous immunoglobulins by the direct method. Pharmeur Bio Sci Notes (2010) 0.76
Thermal stability of human albumin measured by differential scanning calorimetry. II. Effects of isomers of N-acetyltryptophanate and tryptophanate, pH, reheating, and dimerization. Vox Sang (1984) 0.76
Genetic variance and heritability of temperament among Chinese twin infants. Acta Genet Med Gemellol (Roma) (1990) 0.76
Risk factors associated with hepatitis C virus infection in Taiwanese government employees. Epidemiol Infect (2001) 0.75
Immunoglobulin therapy. Lancet (1991) 0.75
Silicone lubricant flushed from disposable syringes: determination by atomic absorption spectrophotometry. J Pharm Sci (1969) 0.75
International collaborative study to evaluate a candidate reference preparation to define an appropriate specified limit of anti-D in intravenous immunoglobulin products. Vox Sang (2005) 0.75
Quantitation of monomeric and non-monomeric forms of albumin. Dev Biol Stand (1980) 0.75
Hepatitis C virus RNA in factor VIII concentrates. Transfusion (1995) 0.75
Thermal stability of human albumin measured by differential scanning calorimetry. I. Effects of caprylate and N-acetyltryptophanate. Vox Sang (1984) 0.75
Reversibility of human immunoglobulin G dimerization. Acta Radiol Suppl (1971) 0.75
Studies on the stability of human gamma globulin. Vox Sang (1967) 0.75
Antibodies to hepatitis A virus in immune serum globulin. J Med Virol (1981) 0.75
The birth and demise of "salt-poor" albumin. Am J Hosp Pharm (1978) 0.75
Detection of HIV-1 by RNA PCR in factor VIII concentrates. Vox Sang (1994) 0.75
Human fibrinogen free of factor XIII: the pursuit of biological zero. Ann N Y Acad Sci (1972) 0.75
Collaborative study for establishment of a global standard for the potency assay of human anti-D immunoglobulin. Pharmeuropa Bio (2004) 0.75
Antibodies to hepatitis A virus in immune serum globulin. Lancet (1980) 0.75
Fibrinopeptide release from fibrinogen Paris I. Thromb Res (1980) 0.75
A urokinase-incubation method for predicting the stability of immune globulin. J Biol Stand (1978) 0.75
International collaborative study to establish immunoglobulin (anti-D test) BRP batch 1. Pharmeuropa Bio (2006) 0.75
Availability of intramuscular immunoglobulin. Lancet (1984) 0.75
Congenital dysfibrinogenemia: fibrinogen Lille. Thromb Res (1978) 0.75
An evaluation of the effects of polyvinylpyrrolidone on blood typing with anti-Rh serum: importance of albumin concentration. Proc Soc Exp Biol Med (1969) 0.75
Production and utilization of canine anti-A and anti-canine gamma-globulin (Coombs') serums. Lab Anim Care (1969) 0.75